Oxytetracycline is one of the most widely used antibiotics in cattle production, prescribed for conditions ranging from respiratory disease and anaplasmosis to pinkeye and footrot. It works by stopping bacterial protein synthesis, making it effective against a broad spectrum of organisms that affect beef and dairy herds. But how well it works, how long it lasts, and what producers need to watch out for depend heavily on the formulation, the route of administration, and the disease being treated.
How Oxytetracycline Works
Oxytetracycline belongs to the tetracycline family of antibiotics. It kills or inhibits bacteria by binding to the 30S ribosomal subunit, the piece of cellular machinery bacteria use to build proteins.1Journal of Biological Chemistry. Biosynthesis of oxytetracycline Without functional proteins, bacteria can’t grow, repair themselves, or reproduce. This mechanism gives oxytetracycline its broad-spectrum reach: it’s effective against both gram-positive and gram-negative bacteria, as well as certain intracellular parasites like Anaplasma marginale.
For cattle producers, this broad spectrum is both the drug’s greatest strength and one reason it gets used so heavily. A single antibiotic that can address respiratory pathogens, tick-borne blood parasites, and common skin and hoof infections has obvious appeal in large-scale operations where quick treatment decisions matter.
Bovine Respiratory Disease and Shipping Fever
The most common reason cattle receive oxytetracycline is bovine respiratory disease (BRD), often called shipping fever. Stressed calves arriving at feedlots after transport are especially vulnerable, and mass medication with oxytetracycline at arrival has been a standard management strategy for decades. In trials with highly stressed calves, intramuscular injections of oxytetracycline at 11 mg/kg body weight for three consecutive days cut the number of treatment days per calf by roughly 21 to 31 percent compared to untreated controls.2PubMed. Mass medication in reducing shipping fever-bovine respiratory disease complex in highly stressed calves
Oxytetracycline is one of many antibiotics used for BRD, and large meta-analyses comparing antibiotic options have catalogued data from dozens of trials across at least 12 different antibiotics.3PubMed Central. A mixed treatment comparison meta-analysis of antibiotic treatments for bovine respiratory disease Where oxytetracycline sits in the ranking depends on the specific pathogen and the formulation used, but its cost and availability keep it among the most commonly chosen options, especially for metaphylaxis (treating an entire group at arrival before clinical signs appear).
When calves with respiratory disease also run high fevers and look visibly depressed, some veterinarians combine oxytetracycline with a non-steroidal anti-inflammatory drug (NSAID). In calves with enzootic bronchopneumonia, the combination of long-acting oxytetracycline with meloxicam produced faster improvement in clinical signs and quicker normalization of body temperature than the antibiotic alone or the antibiotic combined with a steroid.4PubMed. Effect of steroidal and non-steroidal anti-inflammatory drugs in combination with long-acting oxytetracycline on non-specific immunity of calves suffering from enzootic bronchopneumonia That said, a broader systematic review of NSAID use in BRD found that adding an anti-inflammatory did not meaningfully reduce the number of re-treatments compared to antibiotics alone.5PubMed Central. Efficacy of non-steroidal anti-inflammatory drug (NSAID) treatment for bovine respiratory disease: a systematic review and meta-analysis for the European Network for Optimization of Antimicrobial Therapy guidelines The NSAID may help the animal feel better sooner without necessarily changing the overall course of treatment.
Anaplasmosis
Anaplasmosis, caused by the tick-borne blood parasite Anaplasma marginale, is one of the most economically damaging cattle diseases in tropical and subtropical regions. Oxytetracycline is the standard treatment for acute clinical episodes, typically given by injection at labeled doses.6PubMed Central. Failure to Eliminate Persistent Anaplasma marginale Infection from Cattle Using Labeled Doses of Chlortetracycline and Oxytetracycline Antimicrobials It controls the active infection and reduces the severity of clinical signs, which can include fever, anemia, and sudden death in severe cases.
Where the evidence gets frustrating is in clearing the carrier state. Cattle that recover from anaplasmosis remain persistently infected and can serve as reservoirs, spreading the parasite to other animals through ticks. Producers and veterinarians have long hoped that aggressive oxytetracycline treatment could sterilize carriers completely. The research, however, paints a discouraging picture. In one controlled trial, cattle given injectable oxytetracycline subcutaneously at about 20 mg/kg three times at three-week intervals still tested positive for A. marginale 60 days after treatment.7PubMed Central. Failure to Eliminate Persistent Anaplasma marginale Infection from Cattle Using Labeled Doses of Chlortetracycline and Oxytetracycline Antimicrobials Another study testing three different oxytetracycline regimens found that all treated steers remained positive by PCR and serological testing, and blood from those animals could still transmit the infection to a naive calf.8PubMed. Comparison of three oxytetracycline regimes for the treatment of persistent Anaplasma marginale infections in beef cattle
A separate trial from Argentina reported about 50 percent efficacy in sterilizing carrier status with oxytetracycline, suggesting it may work in some animals but not reliably enough to count on.9Veterinary Parasitology: Regional Studies and Reports. Efficacy of long-acting oxytetracycline and imidocarb dipropionate for the chemosterilization of Anaplasma marginale in experimentally infected carrier cattle in Argentina The bottom line for producers: oxytetracycline is effective for treating sick animals, but expecting it to eliminate the parasite from carriers with currently approved doses is unrealistic. Managing anaplasmosis still requires tick control and careful herd management on top of treatment.
Pinkeye and Footrot
Beyond respiratory disease and blood parasites, oxytetracycline sees heavy use against two other common cattle ailments: infectious bovine keratoconjunctivitis (pinkeye) and footrot.
Pinkeye is caused primarily by Moraxella bovis, and long-acting oxytetracycline is a go-to treatment. In a controlled calf study, cultures from treated animals turned negative after a single injection and stayed that way for 14 days, while the untreated controls continued shedding the bacteria throughout that period.10PubMed. Treatment of Moraxella bovis infections in calves using a long-acting oxytetracycline formulation The practical takeaway: catching pinkeye early and treating promptly with long-acting oxytetracycline gives good odds of clearing the infection and reducing spread within the herd.
Footrot is a different story. A network meta-analysis pooling data from multiple trials ranked oxytetracycline third for curing footrot, behind gamithromycin and lincomycin.11PubMed. Network meta-analysis of the therapeutic effects of various antibiotics on footrot in sheep and cattle It still performed significantly better than some alternatives like enrofloxacin, but it’s not the top choice. Complicating matters further, an in vitro study of bacteria isolated from hoof lesions in dairy cattle found that many isolates of Staphylococcus aureus, Fusobacterium necrophorum, and Bacteroides species were resistant to oxytetracycline.12PubMed Central. In vitro and in vivo evaluation of some antimicrobials and disinfectants against bacterial pathogens from hoof lesions in dairy cattle Producers treating chronic or recurring footrot problems with oxytetracycline alone may not see the results they expect, especially in herds where resistant bacteria have established themselves.
Long-Acting Formulations and How They Behave in the Body
Most producers are familiar with long-acting oxytetracycline (often labeled as “LA-200” or similar trade names), which is designed to maintain effective blood levels for an extended period after a single injection. In crossbred male calves given the long-acting formulation intramuscularly, peak blood concentrations were reached within 8 to 10 hours, and the drug stayed above therapeutic levels for up to 84 hours.13PubMed. Some pharmacokinetic parameters and dosage regimens for a long-acting formulation of oxytetracycline in 6- to 8-month-old male calves The intramuscular bioavailability was about 89 percent, meaning nearly all of the injected dose reaches the bloodstream.
Where you inject matters. A study comparing injection sites in ruminant calves found that subcutaneous injection in the neck and intramuscular injection in the hindquarters both caused noticeable irritation at the site, which took about five days to resolve. That irritation actually slowed absorption, keeping oxytetracycline circulating in the blood longer than with other routes.14PubMed. Effect of injection site on the bioavailability of an oxytetracycline formulation in ruminant calves In terms of drug levels, that slower release can be an advantage. But it creates problems at slaughter.
Injection Site Lesions and Meat Quality
Injection site damage is one of the more tangible economic consequences of oxytetracycline use in beef cattle. A study examining yearling cattle injected with long-acting oxytetracycline intramuscularly 28 days before slaughter found that the drug caused injection site lesions and detectable antibiotic residues in both the neck and thigh tissue.15PubMed Central. The effect of administering long-acting oxytetracycline and tilmicosin either by dart gun or by hand on injection site lesions and drug residues in beef cattle The severity varied by administration technique, dose, and injection site. Dart-gun delivery, sometimes used for hard-to-handle cattle, created different lesion patterns than hand injection in a chute.
This is why the beef industry’s Beef Quality Assurance (BQA) guidelines strongly recommend injecting in the neck rather than high-value cuts in the hindquarters. An injection site lesion in a round steak or top sirloin is a direct economic loss. Neck tissue, while still damaged, is lower value and the loss is smaller. Proper needle selection, injection volume limits per site, and adherence to withdrawal periods all reduce the problem but don’t eliminate it entirely.
Safety Risks With Intravenous Use
While intramuscular and subcutaneous injection are the standard routes for long-acting oxytetracycline, intravenous administration of tetracycline-class drugs in cattle carries serious cardiovascular risks. Research examining the cardiovascular effects of IV tetracycline in cows found that rapid injection caused dramatic drops in blood pressure and heart rate, with some cows collapsing shortly after the injection was completed.16PubMed. Cardiovascular effects of intravenous administration of tetracycline in cattle At higher doses given quickly (over about 60 seconds), pulse rates fell as low as 10 to 20 beats per minute, blood pressure dropped to near zero, and severe ECG abnormalities appeared. When the same dose was given slowly over five minutes, none of the cows collapsed. This finding underscores why IV oxytetracycline should only be administered by a veterinarian with careful attention to infusion rate, and why the intramuscular long-acting formulation is strongly preferred for on-farm use.
Withdrawal Periods and Residues in Meat and Milk
Withdrawal periods exist to make sure antibiotic residues have cleared an animal’s tissues before meat or milk enters the human food chain. The specific withdrawal time for oxytetracycline varies by country, formulation, and route of administration, but violating it can result in meat or milk being condemned at inspection. The consequences for consumers are real too: chronic low-level exposure to antibiotic residues in food is a concern for human health.
When withdrawal periods are not respected, the residue levels can be extreme. A study in Tanzania’s Kilosa district found that 85 percent of cattle sampled at market tested positive for oxytetracycline residues, and over two-thirds of those positive samples exceeded acceptable limits for muscle, liver, and kidney tissue.17AOSIS OpenJournals (Onderstepoort Journal of Veterinary Research). Determination of oxytetracycline residues in cattle meat marketed in the Kilosa district, Tanzania Mean residue concentrations across all tissues were many times above the threshold set by international food safety standards. While this study reflects conditions in a specific region with limited regulatory enforcement, it illustrates what happens without proper withdrawal compliance.
For dairy cattle, the picture is more nuanced. Modeling work on oxytetracycline excretion into milk found that because the drug has relatively low milk excretion, the stage of lactation and milking frequency had only minimal effects on how long it takes for residues to clear.18PubMed. Effect of milking interval and lactation stage on withdrawal period: Exemplified with a bovine oxytetracycline lactation physiologically based kinetic model The one exception: milking once a day instead of twice could extend the withdrawal period by about a day. Timing of drug administration relative to milking did not matter for this particular antibiotic.
Intrauterine use adds another wrinkle. When oxytetracycline is infused into the uterus to treat postpartum infections like metritis, the drug quickly diffuses into the bloodstream and then into milk. In one study, 25 out of 32 treated cows still had detectable oxytetracycline in their milk four days after a single intrauterine infusion.19PubMed. A study to examine the relationship between metritis severity and depletion of oxytetracycline in plasma and milk after intrauterine infusion Veterinarians who use this off-label route need to advise producers about appropriate milk withholding, which may differ from the label’s withdrawal period for injectable use.
Antibiotic Resistance
Resistance to tetracyclines in cattle-associated bacteria is well documented and growing. A study of grazing cattle treated with oxytetracycline found that within a short period after treatment, the abundance of seven different tetracycline resistance genes in fecal bacteria increased compared to untreated controls.20PubMed Central. Short-Term Impact of Oxytetracycline Administration on the Fecal Microbiome, Resistome and Virulome of Grazing Cattle This means that every round of oxytetracycline treatment creates selection pressure favoring bacteria that can survive the drug, and those resistant organisms are shed into the environment through manure.
The specifics of which resistance genes dominate depend on which tetracycline analogue is used. Research comparing E. coli from feedlot cattle given either chlortetracycline or oxytetracycline found that the prevalence of particular resistance genes differed depending on which drug the animals received.21PubMed. Characterization of tetracycline resistance genes in Escherichia coli isolated from feedlot cattle administered therapeutic or subtherapeutic levels of tetracycline The researchers concluded that tetracycline analogues should not be treated as interchangeable when evaluating resistance, because the selective pressures they impose are different. This has practical implications for stewardship: rotating between tetracycline-class drugs is not necessarily a resistance management strategy.
In the United States, the regulatory framework around in-feed antibiotics has tightened in recent years. Veterinary Feed Directives now require a licensed veterinarian to authorize the use of medically important antibiotics in feed, including tetracyclines.22Cattle Custom Proceedings (American Association of Bovine Practitioners). Practical and applied use of veterinary feed directives in production The goal is to reduce unnecessary exposure while still allowing producers access to the drugs when they are genuinely needed for disease prevention and treatment. Making cost-effective decisions about in-feed antimicrobials under these rules is more complex than it used to be, and producers increasingly rely on their herd veterinarians to navigate the requirements.
What Happens When Oxytetracycline Reaches the Soil
Because cattle excrete a substantial portion of administered oxytetracycline in their manure, the drug enters the environment whenever that manure is applied to fields. Field studies have tracked what happens next. The parent compound breaks down relatively quickly in soil: one study found oxytetracycline fell below 50 percent of its initial concentration within three weeks.23PubMed. Determination of the persistence of tetracycline antibiotics and their degradates in manure-amended soil using enzyme-linked immunosorbent assay and liquid chromatography-mass spectrometry But its breakdown products, which are structurally similar and still detectable by broad immunoassay methods, persisted for at least five months. The good news is that oxytetracycline appears to bind tightly to soil particles and shows low mobility: trace amounts reached the subsurface in that study, and none was detected in water samples from field lysimeters.
In manure itself, oxytetracycline lingers longer. A separate study of intensive calf farming estimated a half-life of about 30 days in manure, and the compound was still measurable at 820 micrograms per kilogram after five months of composting.24PubMed. Use of oxytetracycline and tylosin in intensive calf farming: evaluation of transfer to manure and soil Once that aged manure was applied to soil, though, oxytetracycline concentrations were at least 10 times lower than the threshold that European regulators set for triggering further environmental risk assessment. So the environmental risk from oxytetracycline in well-managed manure applications appears modest, though the lingering breakdown products and their potential to maintain selective pressure on soil bacteria remain an open question.
Oxytetracycline in manure also affects the composting process itself. Research has shown that the drug inhibits methane production during anaerobic digestion of cow manure and alters the microbial communities responsible for breaking the manure down.25ScienceDirect / Journal of Integrative Agriculture. Effects of Oxytetracycline on Methane Production and the Microbial Communities During Anaerobic Digestion of Cow Manure For operations that rely on anaerobic digesters to manage waste or capture biogas, high levels of oxytetracycline residue in the manure stream could reduce efficiency. This is an area where on-farm waste management and antibiotic use decisions intersect in ways producers don’t always anticipate.